Lori Friedman - Senior Director, Translational Oncology

Lori Friedman

Senior Director, Translational Oncology

"Making a difference to cancer patients has always been my goal. Knowing that my personal goal is in alignment with Genentech's goal is motivational."
Years at Genentech
Awards & Honors

I joined Genentech in 2004 as part of Research Drug Discovery, and am currently Senior Director of the Translational Oncology department. I was attracted to Genentech because of the palpable commitment to helping patients by drawing on scientific insights.

Featured Publication

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.

Nature. 2014 Jun 19;510(7505):407-411.

Ali K, Soond DR, Pineiro R, Hagemann T, Pearce W, Lim EL, Bouabe H, Scudamore CL, Hancox T, Maecker H, Friedman L, Turner M, Okkenhaug K, Vanhaesebroeck B.